Cell Therapy for Brain Tumors: Foundation Hosts Focused Ultrasound Roundtable
Focused Ultrasound FoundationCell Therapy for Brain Tumors: Foundation Hosts Focused Ultrasound Roundtable
Cell Therapy for Brain Tumors: Foundation Hosts Focused Ultrasound Roundtable
The Focused Ultrasound Foundation today announced a historic achievement for the field of noninvasive medicine: more than one million patients worldwide have now been treated with focused ultrasound.
The Focused Ultrasound Foundation has designated Columbia University as a Focused Ultrasound Center of Excellence, recognizing its leadership in research and innovation. Columbia University is the 7th Center of Excellence in the US and the 14th worldwide.
Results from a clinical trial using focused ultrasound to treat Alzheimer’s disease were published today in the Journal of Neurosurgery, representing a critically important new direction in the treatment of this disease.
The 8th International Symposium on Focused Ultrasound – a hybrid virtual and in-person four-day event held in Bethesda, MD –, includes an interactive virtual press briefing featuring the most recent clinical and preclinical advances and emerging applications of focused ultrasound.
Thomas O. Ryder, an investor, entrepreneur, and retired corporate executive, was elected to the Focused Ultrasound Foundation's Board of Directors at their March 1 meeting.
The early-stage, pilot trial aims to establish the safety of destroying a small target in the brain to treat chronic neuropathic pain.
A briefing featuring key data presented at the 6th International Symposium on Focused Ultrasound. Researchers and clinicians will highlight breakthrough advances in the use of focused ultrasound in cancer immunotherapy and for opening the blood-brain barrier (BBB).
Revolutionary Noninvasive Therapy Shows Promise for Immunotherapy and Opening Blood-Brain Barrier to Enable Treatment of Neurological Disease and Cancer
The results of the first ever clinical trial of focused ultrasound to open the blood-brain barrier (BBB) in patients with Alzheimer’s disease were published today in Nature Communications and also presented at the Alzheimer’s Association International Conference (AAIC) in Chicago, Illinois. The pilot trial demonstrated the feasibility and preliminary safety of focally, reversibly and repetitively opening the BBB.
Former CEO of Norfolk Southern and Amtrak, Charles W.
On Tuesday, June 5, Virginia Governor Ralph Northam visited the Focused Ultrasound Foundation and met with the Foundation’s staff as well as with members of the Foundation’s Board and Council, and donors. Virginia House of Delegates Leader David Toscano, representatives from the University of Virginia, and members of the local media were also in attendance.
Virginia Governor Ralph Northam will visit the Focused Ultrasound Foundation to discuss the impact of the State’s investment in pioneering this revolutionary technology. Invited guests will include the media, Foundation Board members, physicians and health industry leaders, and Foundation friends and supporters.
In a North American first, researchers at Sunnybrook Health Sciences Centre in Toronto have launched a pilot clinical trial to determine the safety, feasibility, and preliminary efficacy of using focused ultrasound to help patients with treatment-resistant major depression.
The first patient in a multicenter pivotal trial using focused ultrasound to address the major motor symptoms of Parkinson’s disease has been treated at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center in New York.
The Medical Imaging & Technology Alliance (MITA) announced that it has formed a partnership with the Focused Ultrasound Foundation to raise awareness of focused ultrasound technology among policymakers, payers, and medical specialty societies.
In November 2017, the Focused Ultrasound Foundation launched a new veterinary program to develop focused ultrasound therapies for the treatment of companion animals. The Foundation is currently supporting trials to investigate treating cancer and promote wound healing in pets – and more studies are in the pipeline.
Gary Shapiro, President and CEO of the Consumer Technology Association (CTA)™, which annually produces CES®, the largest technology and innovation show in the world, will deliver a keynote address at the 6th International Symposium on Focused Ultrasound on Tuesday, October 23, 2018, in Reston, Virginia.